Metraipolis › archive › dc_a2d225568f49

Pazopanib in patients with primary multi-metastatic bone Ewing sarcoma — Europe PMC PMID:41211443

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41211443
DOI
10.3389/fonc.2025.1653015
License (as archived)
solo-consultazione
Archived
2026-11-09T03:14:15.015Z
SHA-256 of the archived text
9a119748c792b80ba74b1c248504ea191914f53da552646306c66691eed55f93
Stable URL of this page
https://metraipolis.com/documento/dc_a2d225568f49

How to cite

Pazopanib in patients with primary multi-metastatic bone Ewing sarcoma — Europe PMC PMID:41211443 — Europe PMC (en), https://europepmc.org/article/MED/41211443 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a2d225568f49 (Metraipolis archive dc_a2d225568f49, sha256 9a119748c792b80ba74b1c248504ea191914f53da552646306c66691eed55f93)
BibTeX
@misc{dca2d225568f49,
  title = {Pazopanib in patients with primary multi-metastatic bone Ewing sarcoma — Europe PMC PMID:41211443},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41211443},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a2d225568f49; sha256 9a119748c792b80ba74b1c248504ea191914f53da552646306c66691eed55f93},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41211443. Agents can read the archived copy with the MCP tool read_document.